Component
Phase-II enzyme expression in human PBMCs
Species, preparation, dose and limitations are retained on linked claims.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Hydroxytyrosol at 5 or 25 mg/day for one week did not significantly change PBMC phase-II enzyme expression in a randomized placebo-controlled Latin-square study.
Experimental context and source evidence
- dose
- 5 or 25 mg/day hydroxytyrosol versus placebo
- duration
- 1 week
- evidence_access
- Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
- evidence_scope
- literature_reviewed; model-specific source-derived curation
- experimental_model
- Human participants in a double-blind randomized Latin-square trial
- limitations
- PBMC expression over one week does not exclude effects in other tissues, doses or durations.
- nutrient_topic
- Hydroxytyrosol chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Hydroxytyrosol
- organism
- Human participants in a double-blind randomized Latin-square trial
- plain_language
- Hydroxytyrosol at 5 or 25 mg/day for one week did not significantly change PBMC phase-II enzyme expression in a randomized placebo-controlled Latin-square study.
- primary_references
- One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes. (2015). https://pubmed.ncbi.nlm.nih.gov/25836918/ DOI: 10.1016/j.phrs.2015.03.018
- route
- Oral
- tissue
- PBMC phase-II enzymes
Hydroxytyrosol: mechanism of action and interactions (2026-09-20) · lines 66–75
Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Human participants in a double-blind randomized Latin-square trial · source_derived_draft · unverified_draft
## hydroxytyrosol-phase2-null Hydroxytyrosol at 5 or 25 mg/day for one week did not significantly change PBMC phase-II enzyme expression in a randomized placebo-controlled Latin-square study. Model/species: Human participants in a double-blind randomized Latin-square trial Tissue/system: PBMC phase-II enzymes Exposure: 5 or 25 mg/day hydroxytyrosol versus placebo Route: Oral Duration: 1 week Limits: PBMC expression over one week does not exclude effects in other tissues, doses or durations. Primary reference: One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes. (2015). https://pubmed.ncbi.nlm.nih.gov/25836918/ DOI: 10.1016/j.phrs.2015.03.018 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.